Yesterday was the latest of the European Haemophilia Consortium’s (EHC) fantastic round table meetings. Held in the European Parliament the meeting gathered patients and experts from all over Europe to discuss Hepatitis C and Haemophilia.
It was clear from the discussion that Scotland’s record on treating hepatitis C is good. In many ways Scotland is leading the way with Ireland and Portugal.
The meeting heard how the success rates of the new Direct Acting Antiviral (DAA) treatments, along with their improved tolerability and simpler administration, has made the goal of eradicating hepatitis C in people with bleeding disorders achievable. The health economics mean that it is already a cost effective step to take. However, it will only be achieved where clinicians and patients work together to make an effective case to Government.
As well as some extremely informative clinical presentations there were two excellent presentations from people who were infected.